 |
1 Product |  |
0 Diseases | | 1 Product |
|
0 Trials |  |
5 News |  |
- FMP010 / GSK, Walter Reed Army Institute of Research
Phase classification: Evaluate the Safety and Efficacy of Plasmodium Falciparum Malaria Protein 010 (FMP010) Administered With Adjuvant AS01B (clinicaltrials.gov) - Jun 9, 2020
P1b, N=30, Completed, Sponsor: U.S. Army Medical Research and Development Command
Phase classification: P1 --> P1b
- FMP010 / GSK, Walter Reed Army Institute of Research
Enrollment change: A Study to Determine the Effects of an Investigational Malaria Vaccine Given to Adults Living in the United States and Thereafter to Adults Living in Kenya (clinicaltrials.gov) - May 29, 2015
P1, N=26, Completed, Sponsor: U.S. Army Medical Research and Materiel Command
Phase classification: P1 --> P1b N=56 --> 26
- | FMP010 / GSK, Walter Reed Army Institute of Research
New P1 trial: Evaluate the Safety and Efficacy of Plasmodium Falciparum Malaria Protein 010 (FMP010) Administered With Adjuvant AS01B (clinicaltrials.gov) - May 29, 2015
P1, N=30, Completed, Sponsor: U.S. Army Medical Research and Materiel Command
- FMP010 / GSK, Walter Reed Army Institute of Research
Enrollment change: A Study to Determine the Effects of an Investigational Malaria Vaccine Given to Adults Living in the United States and Thereafter to Adults Living in Kenya (clinicaltrials.gov) - Mar 15, 2012
P1, N=56, Completed, Sponsor: U.S. Army Medical Research and Materiel Command
N=56 --> 26 N=26 --> 56